EPT Disclosure
June 14 2006 - 6:59AM
UK Regulatory
RNS Number:5555E
Cazenove
14 June 2006
FORM 38.5(a)
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITH RECOGNISED INTERMEDIARY STATUS
DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(a) of the Takeover Code)
1. KEY INFORMATION
Name of exempt principal trader Cazenove
Company dealt in Cambridge Antibody Technology
Group
Class of relevant security to which the Ordinary 0.10p
dealings being disclosed relate (Note 1)
Date of dealing 13th June 2006
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of securities Highest price paid Lowest price paid
purchased (Note 3) (Note 3)
200 #13.07p #13.07p
Total number of securities Highest price received Lowest price received
sold (Note 3) (Note 3)
200 #13.07p #13.07p
(b) Derivatives transactions (other than options)
Product name, Long/short Number of securities Price per unit
e.g. CFD (Note 4) (Note 5) (Note 3)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, e.g. Expiry Option
name,e.g selling, securities to price American, date moneypaid/
call purchasing, which the European etc. received
option varying etc option per unit
relates (Note (Note 3)
5)
(ii) Exercising
Product name, e.g. Number of securities Exercise price per unit
call option (Note 3)
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
..............................................................................
..............................................................................
Date of disclosure 14th June 2006
Contact name Barry Page
Telephone number 0207 155 5907
Name of offeree/offeror with which connected AstraZeneca Plc
Nature of connection (Note 6) Acting for AstraZeneca Plc
Notes
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMAKQKPKBKDAAD
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
